Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDM - PubMed (original) (raw)
Comparative Study
. 1994 Dec;43(12):1440-4.
doi: 10.2337/diab.43.12.1440.
Affiliations
- PMID: 7958496
- DOI: 10.2337/diab.43.12.1440
Comparative Study
Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDM
C Y Jeng et al. Diabetes. 1994 Dec.
Abstract
This study was initiated to reevaluate the changes in basal hepatic glucose production (HGP) rate that occur in patients with non-insulin-dependent diabetes mellitus (NIDDM). Measurements were made in 51 volunteers: 18 with normal glucose tolerance and 33 with newly diagnosed NIDDM of varying degrees of severity. To avoid the methodological problems associated with quantifying HGP over short time periods, using non-steady-state isotopic kinetics, radiolabeled glucose was infused for a 12-h period, from 10 P.M. to 10 A.M. with HGP quantified from 9 to 10 A.M.. The results showed that fasting plasma glucose (FPG) concentration and HGP were significantly correlated (r = 0.68, P < 0.001) in patients with NIDDM. However, when the 33 patients with NIDDM were divided into three groups of 11 each on the basis of FPG concentration, it became clear that the relationship between FPG and HGP was complex. Thus, values for HGP in patients with NIDDM and FPG < 180 mg/dl were not higher than in the normal population (1.67 +/- 0.07 vs. 1.69 +/- 0.04 mg.kg-1.min-1, NS). Significant increases (P < 0.01) in HGP above normal were seen in the 11 patients with NIDDM and FPG concentrations between 180 and 250 mg/dl (2.05 +/- 0.07 mg.kg-1.min-1), as well as in those with FPG > 250 mg/dl (2.18 +/- 0.13 mg.kg-1.min-1). Although those with the highest FPG concentrations tended to have the greatest values for HGP, the difference between the latter two groups of patients with NIDDM was not statistically significant. Finally, HGP rates in the 11 patients with FPG concentrations > 250 mg/dl were only 29% higher than values in the control population.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus.
Cusi K, Consoli A, DeFronzo RA. Cusi K, et al. J Clin Endocrinol Metab. 1996 Nov;81(11):4059-67. doi: 10.1210/jcem.81.11.8923861. J Clin Endocrinol Metab. 1996. PMID: 8923861 Clinical Trial. - Relationship between plasma glucose and insulin concentration, glucose production, and glucose disposal in normal subjects and patients with non-insulin-dependent diabetes.
Chen YD, Jeng CY, Hollenbeck CB, Wu MS, Reaven GM. Chen YD, et al. J Clin Invest. 1988 Jul;82(1):21-5. doi: 10.1172/JCI113572. J Clin Invest. 1988. PMID: 3292584 Free PMC article. - Is hepatic glucose production increased in type 2 diabetes mellitus?
Beck-Nielsen H, Hother-Nielsen O, Staehr P. Beck-Nielsen H, et al. Curr Diab Rep. 2002 Jun;2(3):231-6. doi: 10.1007/s11892-002-0088-0. Curr Diab Rep. 2002. PMID: 12643178 Review. - Hepatic sensitivity to insulin: effects of sulfonylurea drugs.
Del Prato S, Vigili de Kreutzenberg S, Riccio A, Tiengo A. Del Prato S, et al. Am J Med. 1991 Jun 24;90(6A):29S-36S. doi: 10.1016/0002-9343(91)90415-t. Am J Med. 1991. PMID: 1872301 Review.
Cited by
- Impaired plasma glucose clearance is a key determinant of fasting hyperglycemia in people with obesity.
Mittendorfer B, van Vliet S, Smith GI, Petersen MC, Patterson BW, Klein S. Mittendorfer B, et al. Obesity (Silver Spring). 2024 Mar;32(3):540-546. doi: 10.1002/oby.23963. Epub 2024 Jan 16. Obesity (Silver Spring). 2024. PMID: 38228469 - Basal insulin requirement in patients with type 1 diabetes depends on the age and body mass index.
Mitsui Y, Kuroda A, Ishizu M, Mori H, Kurahashi K, Kondo T, Yoshida S, Akehi Y, Aihara KI, Endo I, Abe M, Matsuhisa M. Mitsui Y, et al. J Diabetes Investig. 2022 Feb;13(2):292-298. doi: 10.1111/jdi.13547. Epub 2021 May 3. J Diabetes Investig. 2022. PMID: 33740836 Free PMC article. - Mechanism of Action of Inhaled Insulin on Whole Body Glucose Metabolism in Subjects with Type 2 Diabetes Mellitus.
Mehta RJ, Gastaldelli A, Balas B, Ricotti A, DeFronzo RA, Tripathy D. Mehta RJ, et al. Int J Mol Sci. 2019 Aug 29;20(17):4230. doi: 10.3390/ijms20174230. Int J Mol Sci. 2019. PMID: 31470605 Free PMC article. - Mild Physiologic Hyperglycemia Induces Hepatic Insulin Resistance in Healthy Normal Glucose-Tolerant Participants.
Tripathy D, Merovci A, Basu R, Abdul-Ghani M, DeFronzo RA. Tripathy D, et al. J Clin Endocrinol Metab. 2019 Jul 1;104(7):2842-2850. doi: 10.1210/jc.2018-02304. J Clin Endocrinol Metab. 2019. PMID: 30789980 Free PMC article. - Gut ghrelin regulates hepatic glucose production and insulin signaling via a gut-brain-liver pathway.
Lin Y, Liang Z, He L, Yang M, Liu D, Gu HF, Liu H, Zhu Z, Zheng H, Li L, Yang G. Lin Y, et al. Cell Commun Signal. 2019 Jan 25;17(1):8. doi: 10.1186/s12964-019-0321-y. Cell Commun Signal. 2019. PMID: 30683114 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous